April 17 - 18, 2025
Live Stream - Remote Learning
Course# MDM25P05 - Department: Medicine
Registration Fees
$500.00 Physicians
$450.00 Advanced Practice Professionals/Nurses
$150.00 Residents/Fellows
Cancellation Policy
Cancellations received in writing before the April 10, 2025 will be refunded, less an administrative fee of $75. No refunds will be made on cancellations received after that date.
Please submit your cancellation request at
https://tiny.ucsf.edu/cmehelp
Overview
The 5th Annual UCSF Addiction CME Conference aims to increase the core competency of medical teams in the inpatient and outpatient settings to improve care for patients who use drugs and alcohol. This conference will increase skills in diagnosis, assessment, and treatment of common substance use disorders through didactics taught by local addiction experts, as well as small group discussions to apply this knowledge to patient care. This is a Virtual Conference.
Target Audience
Physicians
Nurse practitioners and Physician Associates (PAs)
Topics Covered
- Keynote address from a person with lived experience of Substance Use Disorder (SUD)
- SUD as a brain disease, stigma
- Opioid Use Disorder, including starting buprenorphine and methadone
- Alcohol use disorder
- Benzodiazepine use disorder and withdrawal management
- Stimulant use disorder
- Pregnancy and SUDs
- Pain and SUDs
- Hospital based care for patients with SUDs
- Communication and documentation in caring for patients with SUDs
Accreditation
In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
ACCME Designation Statement: UCSF has approved this program for CME credit: UCSF designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference to claim CME.
Objectives
Attendees completing this course will be able to:
- Apply new knowledge in practice to more often recognize signs of substance use disorders (SUDs)
- Implement screening in practice to confirm SU
- Consider a broader set and combination of evidence-based treatments for opioid, alcohol, and stimulant use disorders in management of SU
Course Outline
** All times indicated below are Pacific Time **
| Day 1: April 17, 2025 | |||
| 8:00am - 8:15am | Welcome from the Conference Co-Chairs: Jesse Ristau MD* and Alex Logan, MD* | ||
| 8:15am -8:55am | Jose P, Drug and Alcohol Counselor | Drug Treatment Program | Keynote Address |
| 8:55am - 9:25am | Johanna Sluser, FNP-C, CARN-AP | Hospital medicine, Psychiatry | Stigma and clinical diagnosis of SUD |
| 9:25am -9:55am | Khaled Moussawi, MD, PhD - University of California San Francisco | Neurology | SUD as a brain disease |
| Break - 15 mins | |||
| 10:10am -11:10am | Andy Tompkins*, MD | Psychiatry, OTP | OUD diagnosis and methadone induction |
| 11:10am -12:10pm | Christy Soran*, MD, MPH | Primary Care, OBIC | Complex Buprenorphine Inductions |
| Lunch Break – 12:10pm - 1:40pm | |||
| 1:40pm -2:20pm | Small Groups | Case 1: OUD diagnosis and treatment | |
| 2:20pm -2:35pm | Alex Logan*, MD | Primary Care, Inpatient Consult | Rapid review of Case 1 Clinical Pearls |
| Break – 15 mins | |||
| 2:50pm -3:50pm | Ayesha Appa*, MD | Internal Medicine | Stimulants, drug involved deaths |
| 3:50pm -4:50pm | Triveni Defries, MD* | Internal Medicine | Alcohol Use Disorder: Diagnosis and Treatment |
| 4:50pm -5:00pm | Closing | ||
| Day 2: April 18, 2025 | |||
| 8:00am -8:15am | Introductions: Jesse Ristau MD* and Alex Logan, MD* | ||
| 8:15am -8:55am | Dianna Coffa, MD* | Family & Community Medicine, ZSFG | Communication with patients who use substances |
| 8:55am -9:55am | Tauheed Zaman, MD* | Psychiatry, SFVA | Benzodiazepine Use disorder and detoxification |
| Break – 15 mins | |||
| 10:10am -11:10am | Sujatha Sankaran*, MD | Hospital Medicine | Hospital based care for patients with SUD including Opioid Withdrawal Management |
| 11:10am-12:10pm | Hannah Snyder, MD* | Family & Community Medicine, ZSFG | Telehealth and Patient Centered Documentation |
| Lunch Break - 12:10pm - 1:40pm | |||
| 1:40pm -2:20pm | Small Groups | Case 2: Complex care inpt, outpt, multiple substances, utox (includes 5min of transition time) | |
| 2:20pm -2:35pm | Jessica Ristau*, MD | Primary care and Inpatient consult | Rapid Review of Case 2 Clinical Pearls |
| Break - 15 mins | |||
| 2:50pm -3:50pm | Mishka Terplan*, MD | OB/GYN | Pregnancy and SUD |
| 3:50pm -4:50pm | Elizabeth Abbs | Internal Medicine | Pain and SUD |
| 4:50pm -5:00pm | Closing | ||
Course Chairs
Jessica Ristau, MD*
Assistant Professor
Alex Logan, MD*
Assistant Professor
* Board Certified or Certified in Specialty as Addiction Specialists
Faculty
Elizabeth Abbs
Ayesha Appa, MD*
Dianna Coffa, MD
Triveni Defries, MD
Alex Logan, MD
Khaled Moussawi, MD, PhD - UCSF
Jose P, Drug and Alcohol Counselor
Jessica Ristau, MD
Sujatha Sankaran, MD
Johanna Sluser, FNP-C, CARN-AP
Hannah Snyder, MD
Christy Soran, MD, MPH
Mishka Terplan, MD
Andy Tompkins, MD
Tauheed Zaman, MD
Previous Courses